Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVAS-an interesting california-based biotech company here -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (80)	3/27/2002 6:36:19 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 126

<<Preliminary smoke signals is wrong direction but still unclear. And that 1.5m day in March?>> At least one person think different, Mark Lampert from BVF. He increased position in last two months from ~0.6 M to ~3.16 M shares. Why? Last time (mid 2000) his gain on CVAS trading was second largest one, first place was on OSIP. Interesting to note that after PIIa data he did strongly suggested (and spread rumor) that rNIF did not show any efficacy and will not be in PIIb. Go figure??? Miljenko PS: FWIW, gain from CLTX went into additional CVAS shares.